Product name:Cediranib
CAS:288383-20-0
Molecular Formula:C25H27FN4O3
Formula Weight:450.51g/mol
Description:
Cediranib is a potent inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases.It is undergoing Phase I clinical trials for the treatment of non-small cell lung cancer, kidney cancer, and colorectal cancer in adults, as well as tumors of the central nervous system in children.